Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
169.70
+2.79 (1.67%)
Dec 5, 2025, 4:00 PM EST - Market closed
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,800 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,800
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,484,940
Profits / Employee
-$131,601
Market Cap
10.31B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
JAZZ News
- 21 hours ago - Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting - PRNewsWire
- 23 hours ago - Trials, Sales Wins Sends Jazz Pharmaceuticals Higher - FXEmpire
- 3 days ago - Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium - PRNewsWire
- 3 days ago - Jazz Pharmaceuticals plc (JAZZ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference - PRNewsWire
- 18 days ago - Jazz Pharmaceuticals: Stock Soars On Zanidatamab Data - I'm Still On The Fence - Seeking Alpha
- 18 days ago - Jazz Pharmaceuticals' And Zymeworks' Ziihera Success: A Pleasant Surprise - Seeking Alpha
- 18 days ago - Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans - Benzinga